Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Journal of Clinical Medicine
|
March 11, 2023
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program
Tze-Fan Chao, Martin Unverdorben, Paulus Kirchhof, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
June 29, 2026
Edoxaban versus Apixaban Outcomes Differences in 8,444 Patients with Atrial Fibrillation from Italy: A Real-World Use Comparison
Angel Valladares, Joseph Imperato, Sidharth Gupta, et al.
Clinical Cardiology
|
February 27, 2025
Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF Program
Raffaele De Caterina, Martin Unverdorben, Cathy Chen, et al.
The Journal of Invasive Cardiology
|
April 16, 2005
Evaluation of the Coroflex Theca-Stent for reduction of restenosis (ECORI)
Martin Unverdorben, Ralf Degenhardt, Peter Sick, et al.
JACC. Advances
|
February 26, 2026
Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making: ENGAGE AF-TIMI 48 Trial Analysis
C Michael Gibson, Cathy Chen, Jacqueline Buros-Novik, et al.
European Heart Journal Open
|
March 31, 2025
Edoxaban treatment in routine clinical practice is highly concordant with the 2020 European Society of Cardiology atrial fibrillation guidelines: results from the noninterventional Global ETNA-AF programme
Doralisa Morrone, Leon Dinshaw, José Antonio Gordillo de Souza, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 31, 2024
Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial
Raúl Moreno, José Souza, Rüdiger Smolnik, et al.
JACC. Advances
|
November 20, 2025
Edoxaban Dose Adjustment and Age-Associated Outcomes in Patients With Atrial Fibrillation Post-Transcatheter Aortic Valve Replacement
Nicolas M Van Mieghem, Cathy Chen, Christian Hengstenberg, et al.
American Heart Journal
|
September 2, 2018
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial
Nicolas M Van Mieghem, Martin Unverdorben, Marco Valgimigli, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 7, 2010
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter
Martin Unverdorben, Franz X Kleber, Hubertus Heuer, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Journal of Clinical Medicine
|
March 11, 2023
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program
Tze-Fan Chao, Martin Unverdorben, Paulus Kirchhof, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
June 29, 2026
Edoxaban versus Apixaban Outcomes Differences in 8,444 Patients with Atrial Fibrillation from Italy: A Real-World Use Comparison
Angel Valladares, Joseph Imperato, Sidharth Gupta, et al.
Clinical Cardiology
|
February 27, 2025
Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF Program
Raffaele De Caterina, Martin Unverdorben, Cathy Chen, et al.
The Journal of Invasive Cardiology
|
April 16, 2005
Evaluation of the Coroflex Theca-Stent for reduction of restenosis (ECORI)
Martin Unverdorben, Ralf Degenhardt, Peter Sick, et al.
JACC. Advances
|
February 26, 2026
Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making: ENGAGE AF-TIMI 48 Trial Analysis
C Michael Gibson, Cathy Chen, Jacqueline Buros-Novik, et al.
European Heart Journal Open
|
March 31, 2025
Edoxaban treatment in routine clinical practice is highly concordant with the 2020 European Society of Cardiology atrial fibrillation guidelines: results from the noninterventional Global ETNA-AF programme
Doralisa Morrone, Leon Dinshaw, José Antonio Gordillo de Souza, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 31, 2024
Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial
Raúl Moreno, José Souza, Rüdiger Smolnik, et al.
JACC. Advances
|
November 20, 2025
Edoxaban Dose Adjustment and Age-Associated Outcomes in Patients With Atrial Fibrillation Post-Transcatheter Aortic Valve Replacement
Nicolas M Van Mieghem, Cathy Chen, Christian Hengstenberg, et al.
American Heart Journal
|
September 2, 2018
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial
Nicolas M Van Mieghem, Martin Unverdorben, Marco Valgimigli, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 7, 2010
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter
Martin Unverdorben, Franz X Kleber, Hubertus Heuer, et al.
Page
of 8